Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

被引：9
|
作者：
Nagel, Sylke [3 ]
Califano, Raffaele [2 ]
Thatcher, Nicholas [1 ]
Blackhall, Fiona [1 ]
机构：
[1] Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Osped Santa Maria Misericordia, SC Oncol Med, I-06120 Perugia, Italy
[3] Martha Maria Hosp, D-06120 Halle, Germany
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 18期
关键词：
carboplatin; chemotherapy; gemcitabine; non-small-cell lung cancer;
D O I：
10.1517/14656566.8.18.3265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status is a platinum drug in combination with one of gemcitabine, paclitaxel, vinorelbine or docetaxel. Although cisplatin is generally the favoured platinum agent, gemcitabine partnered with carboplatin is convenient to administer and has a favourable toxicity profile. Here, the pharmacology, preclinical and clinical data to support the use of this regimen for the treatment of advanced non-small-cell lung cancer is evaluated.
引用
收藏
页码：3265 / 3275
页数：11
相关论文
共 50 条
  • [1] Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer
    Leow, CH
    Liam, CK
    RESPIROLOGY, 2005, 10 (05) : 629 - 635
  • [2] Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Zatloukal, P
    Petruzelka, L
    LUNG CANCER, 2002, 38 : S33 - S36
  • [3] Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Park, SH
    Jeong, SH
    Kyung, SY
    Lim, YH
    An, CH
    Lee, SP
    Park, JW
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    MEDICAL ONCOLOGY, 2005, 22 (04) : 359 - 366
  • [4] Gemcitabine and carboplatin combination in patients with advanced and locally advanced stage non-small cell lung cancer
    Ozturk, Nevzat
    Erbaycu, Ahmet Emin
    Gulpek, Mehmet
    Tuksavul, Fevziye
    Uslu, Ozgur
    Guclu, Salih Zeki
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2008, 23 (02): : 72 - 80
  • [5] THE COMBINATION CHEMOTHERAPY OF GEMCITABINE, CARBOPLATIN AND BEVACIZUMAB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Kim, Bong Seog
    Ahn, Young Mi
    Lee, Moon Hyung
    Suh, Kang Heum
    Nam, Seung-Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1158 - S1158
  • [6] Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical Trial
    Jin‐ji Yang
    ChineseJournalofCancerResearch, 2012, 24 (02) : 97 - 102
  • [7] Nedaplatin/gemcitabine versus carboplatin/gemcitabine in treatment of advanced non-small cell lung cancer: A randomized clinical trial
    Yang, Jin-ji
    Zhou, Qing
    Liao, Ri-qiang
    Huang, Yi-sheng
    Xu, Chong-rui
    Wang, Zhen
    Wang, Bin-chao
    Chen, Hua-jun
    Wu, Yi-long
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (02) : 97 - 102
  • [8] Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
    Yu, Xun
    Zhang, Lemeng
    Chen, Jianhua
    OPEN MEDICINE, 2018, 13 (01): : 142 - 147
  • [9] A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer
    Tognoni, A
    Pensa, F
    Vaira, F
    Vigani, A
    Canessa, P
    Sinaccio, G
    Pronzato, P
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (03) : 296 - 300
  • [10] Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer
    Harper, P
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 2 - 12
12345